Current status of liposomal porphyrinoid photosensitizers

Drug Discovery Today

Volumn 18, Issue 15-16, 2013, Pages 776-784

  Skupin Mrugalska, Paulina ^a   Piskorz, Jaroslaw ^a   Goslinski, Tomasz ^a   Mielcarek, Jadwiga ^a   Konopka, Krystyna ^b   Düzgüneş, Nejat ^b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b UNIVERSITY OF THE PACIFIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; FOSLIP; FOSPEG; LIPOSOME; PHOTOFRIN; PHOTOFRIN I; PHOTOSENSITIZING AGENT; PORPHYRIN; PORPHYRIN DERIVATIVE; TEMOPORFIN; TETRAKIS(3 HYDROXYPHENYL)CHLORIN; UNCLASSIFIED DRUG; VERTEPORFIN;

ANTIANGIOGENIC ACTIVITY; APOPTOSIS; AQUEOUS SOLUTION; CYTOTOXICITY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG SOLUBILITY; ENCAPSULATION; ENDOTHELIUM CELL; GENE EXPRESSION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HYDROPHOBICITY; INFECTION; INFLAMMATION; LIPOPROTEIN BLOOD LEVEL; LIPOSOMAL DELIVERY; PHASE TRANSITION; PHOTODYNAMIC THERAPY; PHOTODYNAMICS; PHOTOSENSITIVITY; PHOTOTOXICITY; PHYSICAL CHEMISTRY; RED LIGHT; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SKIN DISEASE; SURFACE CHARGE; TUMOR GROWTH; UNSPECIFIED SIDE EFFECT; ZETA POTENTIAL;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG DELIVERY SYSTEMS; HUMANS; LIPOSOMES; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS;

EID: 84881145875     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2013.04.003     Document Type: Review

References (78)

1. R.R. Allisson, and C.H. Sibata Oncologic photodynamic therapy photosensitizers: a clinical review Photodiagn. Photodyn. Ther. 7 2010 61 75
2. S. Yano Current states and future views in photodynamic therapy J. Photochem. Photobiol. C 12 2011 46 67
3. Y.N. Konan State of the art in the delivery of photosensitizers for photodynamic therapy J. Photochem. Photobiol. B 66 2002 89 106 (Pubitemid 34240266)
4. Gupta, A. et al. Shining light on nanotechnology to help repair and regeneration. Biotechnol. Adv. [Epub ahead of print], available at: http://dx.doi.org/10.1016/j.biotechadv.2012.08.003
5. Y-Y. Huang Can nanotechnology potentiate photodynamic therapy? Nanotechnol. Rev. 1 2012 111 146
6. D. Veres Comparison of binding ability and location of two mesoporphyrin derivatives in liposomes explored with conventional and site-selective fluorescence spectroscopy J. Phys. Chem. B 116 2012 9644 9652
7. I. Bronshtein Porphyrin depth in lipid bilayers as determined by iodide and parallax fluorescence quenching methods and its effect on photosensitizing efficiency Biophys. J. 87 2004 1155 1164 (Pubitemid 39095092)
8. A.S.L. Derycke, and P.A.M. de Witte Liposomes for photodynamic therapy Adv. Drug Deliv. Rev. 56 2004 17 30 (Pubitemid 38045422)
9. B. Chen Liposomal delivery of photosensitizing agents Expert Opin. Drug Deliv. 2 2005 477 487
10. C.S. Jin, and G. Zheng Liposomal nanostructures for photosensitizer delivery Lasers Surg. Med. 43 2011 734 748
11. A.M. Richter Preliminary studies on a more effective phototoxic agent than hematoporphyrin J. Natl. Cancer Inst. 79 1987 1327 1332 (Pubitemid 18036738)
12. U. Schmidt-Erfurth, and T. Hasan Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration Surv. Ophthalmol. 45 2000 195 214
13. W.M. Chan Verteporfin PDT for non-standard indications - a review of current literature Arch. Clin. Exp. Ophthalmol. 248 2010 613 626
14. B.M. Aveline The effects of aggregation, protein binding and cellular incorporation on the photophysical properties of benzoporphyrin derivative monoacid ring A (BPDMA) J. Photochem. Photobiol. B 30 1995 161 169
15. A.M. Richter Liposomal delivery of a photosensitizer, benzoporphyrin derivative monoacid ring A (BPD), to tumor tissue in a mouse tumor model Photochem. Photobiol. 57 1993 1000 1006
16. R.K. Chowdhary Drug release characteristics of lipid based benzoporphyrin derivative J. Pharm. Pharm. Sci. 6 2003 13 19 (Pubitemid 37207238)
17. R. Liu Water-Insoluble Drug Formulation 2nd edn 2008 CRC Press 688
18. K. Kurohane Photodynamic therapy targeted to tumor-induced angiogenic vessels Cancer Lett. 167 2001 49 56 (Pubitemid 32373268)
19. B. Chen Disparity between prostate tumor interior versus peripheral vasculature in response to verteporfin-mediated vascular-targeting therapy Int. J. Cancer 123 2008 695 701 (Pubitemid 351898430)
20. K. Ichikawa Antiangiogenic photodynamic therapy (PDT) using Visudyne causes effective suppression of tumor growth Cancer Lett. 205 2004 39 48 (Pubitemid 38230137)
21. K. Ichikawa PEGylation of liposome decreases the susceptibility of liposomal drug in cancer photodynamic therapy Biol. Pharm. Bull. 27 2004 443 444 (Pubitemid 41685498)
22. N. Oku, and T. Ishii Antiangiogenic photodynamic therapy with targeted liposomes Methods Enzymol. 465 2009 313 330
23. K. Ichikawa Antiangiogenic photodynamic therapy (PDT) by using long-circulating liposomes modified with peptide specific to angiogenic vessels Biochim. Biophys. Acta 1669 2005 69 74 (Pubitemid 40544523)
24. Y. Takeuchi Polycation liposome enhances the endocytic uptake of photosensitizer into cells in the presence of serum Bioconjug. Chem. 14 2003 790 796 (Pubitemid 36875439)
25. Y. Takeuchi Intracellular target for photosensitization in cancer antiangiogenic photodynamic therapy mediated by polycation liposome J. Control. Release 97 2004 231 240 (Pubitemid 38759480)
26. M.O. Senge, and J.C. Brandt Temoporfin (Foscan, 5,10,15,20-tetra(m- hydroxyphenyl) chlorin) - a second-generation photosensitizer Photochem. Photobiol. 87 2011 1240 1269
27. R. Bonnett Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumor photosensitizers Biochem. J. 261 1989 277 280 (Pubitemid 19174790)
28. J. Kuntsche Temoporfin-loaded liposomes: physicochemical characterization Eur. J. Pharm. Sci. 40 2010 305 315
29. C.F. Compagnin Meta-tetra(hydroxyphenyl)chlorin-loaded liposomes sterically stabilised with poly(ethylene glycol) of different length and density: characterisation, in vitro cellular uptake and phototoxicity Photochem. Photobiol. Sci. 10 2011 1751 1759
30. D. Kachatkou Unusual photoinduced response of mTHPC liposomal formulation (Foslip) Photochem. Photobiol. 85 2009 719 724
31. V. Reshetov Redistribution of meta-tetra(hydroxyphenyl)chlorin (m-THPC) from conventional and PEGylated liposomes to biological substrates Photochem. Photobiol. Sci. 10 2011 911 919
32. A. Petri Comparative characterization of the cellular uptake and photodynamic efficiency of Foscan and Fospeg in a human prostate cancer cell line Photodiagn. Photodyn. Ther. 9 2012 344 354
33. H. Hefesha Transfer mechanism of temoporfin between liposomal membranes J. Control. Release 150 2011 279 286
34. V. Reshetov Interaction of liposomal formulations of meta- tetra(hydroxyphenyl)chlorin (Temoporfin) with serum proteins: protein binding and liposome destruction Photochem. Photobiol. 88 2012 1256 1264
35. C. Bombelli New cationic liposomes as vehicles of m-tetrahydroxyphenyl chlorin in photodynamic therapy of infectious diseases Mol. Pharm. 5 2008 672 679
36. C. Bombelli Efficiency of liposomes in the delivery of a photosensitizer controlled by the stereochemistry of a gemini surfactant component Mol. Pharm. 7 2009 130 137
37. K. Yang Antimicrobial peptide-modified liposomes for bacteria targeted delivery of temoporfin in photodynamic antimicrobial chemotherapy Photochem. Photobiol. Sci. 10 2011 1593 1601
38. E.B. Gyenge Cellular and molecular effects of the liposomal mTHPC derivative Foslipos in prostate carcinoma cells in vitro Photodiagn. Photodyn. Ther. 8 2011 86 96
39. E.B. Gyenge Effects of hypericin and a chlorin based photosensitizer alone or in combination in squamous cell carcinoma cells in the dark Photodiagn. Photodyn. Ther. 9 2012 321 331
40. T. Kiesslich Comparative characterization of the efficiency and cellular pharmacokinetics of Foscan- and Foslip-based photodynamic treatment in human biliary tract cancer cell lines Photochem. Photobiol. Sci. 6 2007 619 627 (Pubitemid 46889468)
41. B. Pegaz Photothrombic activity of m-THPC-loaded liposomal formulations: preclinical assessment on chick chorioallantoic membrane model Eur. J. Pharm. Sci. 28 2006 134 140
42. M.J. Bovis Improved in vivo delivery of m-THPC via pegylated liposomes for use in photodynamic therapy J. Control. Release 157 2012 196 205
43. S.D.J.H. De Visscher Fluorescence localization and kinetics of mTHPC and liposomal formulations of mTHPC in the window-chamber tumor model Lasers Surg. Med. 43 2011 528 536
44. H.P. Lassalle Correlation between in vivo pharmacokinetics, intratumoral distribution and photodynamic efficiency of liposomal mTHPC J. Control. Release 134 2009 118 124
45. N. Bendsoe Fluorescence monitoring of a topically applied liposomal temoporfin formulation and photodynamic therapy of nonpigmented skin malignancies J. Environ. Pathol. Toxicol. Oncol. 26 2007 117 126 (Pubitemid 47298899)
46. M.A. D'Hallewin Photodynamic therapy with intratumoral administration of lipid-based mTHPC in a model of breast cancer recurrence Lasers Surg. Med. 40 2008 543 549
47. A. Hansch Photodynamic treatment as a novel approach in the therapy of arthritic joints Lasers Surg. Med. 40 2008 265 272 (Pubitemid 351628529)
48. E. Paszko Transferrin conjugation does not increase the efficiency of liposomal Foscan during in vitro photodynamic therapy of oesophageal cancer Eur. J. Pharm. Sci. 48 2013 202 210
49. A. Casas, and A. Batlle Aminolevulinic acid derivatives and liposome delivery as strategies for improving 5-aminolevulinic acid-mediated photodynamic therapy Curr. Med. Chem. 13 2006 1157 1168
50. K. Christiansen 5-ALA for photodynamic photorejuvenation - optimization of treatment regime based on normal-skin fluorescence measurements Lasers Surg. Med. 39 2007 302 310 (Pubitemid 46717529)
51. J.S. An 0.5% liposome-encapsulated 5-aminolevulinic acid (ALA) photodynamic therapy for acne treatment J. Cosmet. Laser. Ther. 13 2011 28 32
52. J. de Leeuw Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid 0.5% liposomal spray and intense pulsed light in combination with topical keratolytic agents J. Eur. Acad. Dermatol. 24 2010 460 469
53. C.K. Yeung Liposome-encapsulated 0.5% 5-aminolevulinic acid with intense pulsed light for the treatment of inflammatory facial acne: a pilot study Dermatol. Surg. 37 2011 450 459
54. P. Bjerring Skin fluorescence controlled photodynamic photorejuvenation (wrinkle reduction) Lasers Surg. Med. 41 2009 327 336
55. E.K. Oh Retained topical delivery of 5-aminolevulinic acid using cationic ultradeformable liposomes for photodynamic therapy Eur. J. Pharm. Sci. 44 2011 149 157
56. B. Osiecka In vitro and in vivo matrix metalloproteinase expression after photodynamic therapy with a liposomal formulation of aminolevulinic acid and its methyl ester Cell. Mol. Biol. Lett. 15 2010 630 650
57. P.A. Barrett Phthalocyanines. Part VII. Phthalocyanine as a coordinating group. A general investigation of the metallic derivatives J. Chem. Soc. 1936 1719 1736
58. E. Reddi Liposome- or LDL-administered Zn (II)-phthalocyanine as a photodynamic agent for tumours. I. Pharmacokinetic properties and phototherapeutic efficiency Br. J. Cancer 61 1990 407 411 (Pubitemid 20106015)
59. H.L.L.M. van Leengoed In vivo fluorescence and photodynamic activity of zinc phthalocyanine administered in liposomes Br. J. Cancer 69 1994 840 845 (Pubitemid 24140661)
60. C.A. de Oliveira Photoinactivation of different human tumor cell lines and sheep red blood cells in vitro by liposome-bound Zn(II) phthalocyanine: effects of cholesterol J. Photochem. Photobiol. B 100 2010 92 99
61. A. Aygun Investigation of factors affecting controlled release from photosensitive DMPC and DSPC liposomes Appl. Biochem. Biotechnol. 167 2012 743 757
62. D.S. Maranho Photoinduced nitric oxide and singlet oxygen release from ZnPc liposome vehicle associated with the nitrosyl ruthenium complex: synergistic effects in photodynamic therapy application Photochem. Photobiol. 85 2009 705 713
63. G.C. Bolfarini In vitro evaluation of combined hyperthermia and photodynamic effects using magnetoliposomes loaded with cucurbituril zinc phthalocyanine complex on melanoma. J. Photochem. Photobiol. B 115 2012 1 4
64. J. Soriano Cell uptake of Zn(II)-phthalocyanine-containing liposomes by clathrin-mediated endocytosis Histochem. Cell Biol. 133 2010 449 454
65. K. Nawalany Comparison of photodynamic efficacy of tetraarylporphyrin pegylated or encapsulated in liposomes: in vitro studies J. Photochem. Photobiol. B 97 2009 8 17
66. K. Nawalany Novel nanostructural photosensitizers for photodynamic therapy: in vitro studies Int. J. Pharm. 430 2012 129 140
67. S. Ferro Efficient photoinactivation of methicillin-resistant Staphylococcus aureus by a novel porphyrin incorporated into a poly-cationic liposome Int. J. Biochem. Cell Biol. 39 2007 1026 1034 (Pubitemid 46575332)
68. D.M. Gardner Association of acenaphthoporphyrins with liposomes for the photodynamic treatment of leishmaniasis Photochem. Photobiol. 86 2010 645 652
69. V.M. Taylor In vitro and in vivo studies of the utility of dimethyl and diethyl carbaporphyrinketals in treatment of cutaneous leishmaniasis Antimicrob. Agents Chemother. 55 2011 4755 4764
70. N. Nombona Synthesis of phthalocyanine conjugates with gold nanoparticles and liposomes for photodynamic therapy J. Photochem. Photobiol. B 107 2012 35 44
71. J.P.F. Longo Photodynamic therapy with aluminum-chlorophtalocyanine induces necrosis and vascular damage in mice tongue tumors J. Photochem. Photobiol. B 94 2009 143 146
72. J.P.F. Longo Photodynamic therapy disinfection of carious tissue mediated by aluminum-chloride-phthalocyanine entrapped in cationic liposomes: an in vitro and clinical study Lasers Med. Sci. 27 2012 575 584
73. N.B.R. Vittar Cellular inactivation and antitumor efficacy of a new zinc phthalocyanine with potential use in photodynamic therapy Int. J. Biochem. Cell Biol. 40 2008 2192 2205
74. A. Szurko Spectroscopic and biological studies of a novel synthetic chlorin derivative with prospects for use in PDT Bioorg. Med. Chem. 17 2009 8197 8205
75. J. Zhang Synthesis and photobiological study of a novel chlorin photosensitizer BCPD-18MA for photodynamic therapy Bioorg. Med. Chem. 19 2011 5520 5528
76. A. Pashkovskaya Light-triggered liposomal release: membrane permeabilization by photodynamic action Langmuir 26 2010 5726 5733
77. M. Nowakowska Novel nanostructural hybride materials for photodynamic therapy Macromol. Symp. 279 2009 132 137
78. S.K. Janardhanan Architectonics of phage-liposome nanowebs as optimized photosensitizer vehicles for photodynamic cancer therapy Mol. Cancer Ther. 9 2010 2524 2535